Blueprint receives the BioFinland Award 2017

Published on March 29, 2017

We are very proud and thankful to receive the BioFinland Award 2017, today on March 29th. This is a great recognition to the whole team that constantly works to bring genetic testing of inherited disorders into mainstream healthcare, cost efficiently without ever compromising quality. The awards is presented by the Finnish Bioindustries FIB, Finland’s biotechnology industry association.

The BioFinland award is given to a Finnish person, organisation or company, whos innovation in the bioindustry sector has evolved into an internationally significant product, that brings a positive image to the sector and international visibility. The award is presented every second year and the previous winners have been: Finnzymes Oy (v. 2007), Biosilta Oy (2009), Oncos Therapeutics (2011) Glykos Finland Oy (2013) ja Biovian Oy (2015). 

”Blueprint Genetics is an example of a company that quickly has gone global in a segment where Finland is especially strong”, says Timo Veromaa, chairman of Finnish Bioindustries FIB and the jury.

We thank the jury for this recognition, and feel empowered to continue on the path we have taken.

Learn more

About Finnish Bioindustries FIB

Finnish Bioindustries FIB is Finland’s biotechnology industry association, established in 1997. It is a private, independent non-profit organisation. Member companies represent all life science areas, from health care and functional food to biomaterials. In addition industry organisations such as Chemical Industry Federation, Pharma Industry Finland, Finnish Food and Drink Industries’ Federation, Finnish Forest Industries Federation and Finnish Crop Protection Association are members of FIB.

While the industry is rapidly developing, it is vital for biotechnology companies, trade organisations, authorities, researchers, research units, universities, technology organisations and financiers to attain close cooperation with each other. Finnish Bioindustries promotes national and international networking and information transfer between the different players in the field. Being a technology-intensive industry, many of the biotechnology issues concern research and technology. Finnish Bioindustries participates in national and international technology programs, actively exploits finance systems and promotes technology transfer. One of the main tasks is to help the work of commercializing new areas of biotechnology.

Start-up hi-tech companies have the opportunity to share their experience and problems with each other using the platform provided by Finnish Bioindustries.

Extensive legislation in Finland and Europe regulates the activities of the industry. Finnish Bioindustries supports national and international cooperation for the preparation and surveillance of biotechnology legislation.

Finnish Bioindustries is a national member of EuropaBio (European Association for Biotechnology), which was founded in 1996 to promote the European biotechnology industry. FIB is also a member of the US based BIO (Biotechnology Industry Organisation) and the Australian AusBiotech.

Learn more

Last modified: 03.29.2017


Blueprint Genetics expands capabilities in the detection and confirmation of difficult-to-sequence regions

Published on October 17, 2018

The latest advancement in Blueprint Genetics’ production environment involves customized sequencing solutions for difficult-to-sequence genes, designed to maximize detection of clinically relevant variants. Currently, the most extensive developments are in genes SMN1/SMN2, PKD1 and RPGR (ORF15), associated with spinal muscular atrophy, autosomal dominant polycystic kidney disease and X-linked retinitis pigmentosa,…

Read more

Subscribe to our newsletter